3rd Breast and Gynecological International Cancer Conference

13. 1. 2011 - 14. 1. 2011, Cairo, Egypt

Hlavní témata:

  • Biology-Driven Selection of Adjuvant/Neoadjuvant Therapy of Primary Breast Cancer.
  • State of the Art Anti-HER2 Therapy for Breast Cancer.
  • Multidisciplinary Management of Metastatic Breast Cancer.
  • The Concept of Personalised Medicine : is Breast Cancer the New Target ?
  • State of the Art in the Adjuvant Chemotherapy in Breast Cancer: When to Use and When Not?
  • Management of Triple Negative Breast Cancer Including PARP Inhibitors.
  • Management of Women Who are at Increased Risk of Breast Cancer.
  • Emerging Targeted Therapies in Breast Cancer .
  • Primary Systemic Therapy in Breast Cancer: Novel Molecular Concepts.
  • Sentinel Node Before and After Neoadjuvant Therapy.
  • Decision Factors for Adjuvant Chemotherapy.
  • Selection of Hormonal Treatment for Postmenopausal Breast Cancer Patients.
  • What are Adequate Margins with Breast Conserving Therapy?
  • Reconstruction Pros and Cons of Immediate Versus Delayed When Radiation is Necessary.
  • Contact X-ray Applications in Breast and Gynecological Malignancies.
  • HDR Interstitial Brachytherapy in Breast Cancer for Local Recurence After Initial Conservative Treatment.
  • Do we Need to Reoperate the Positive SNB and Prognostic Value of the I+ and Micrometastatic SNB.
  • Value of Hepatic Metastatectomy in Stage IV Breast Cancer .
  • Partial Breast Radiation.
  • Minimizing Local Recurrence: What is Proven and What is Not?
  • HER2 Testing in Breast Cancer: Pitfalls.
  • Recent Advances in HPV Research.
  • New ASCCP Guidelines for the Management of Abnormal Pap Smear and Staging Advances in Gynecologic Cancers.
  • Can we Blame Genes in the ERBB2 Amplicon for Trastuzumab Resistance?
  • Cutting Edge of Breast Imaging with Mammography, Utrasound and Breast MRI.
  • International Cooperation in the Field of Modern Oncology : Is It Only Useful for Long-Term Research or for the Practical Care of Egyptian Patients ?
  • Cyperknife Value in Breast Cancer.

Aktivní účast



Web: http://www.bgicc.e.../experts-2011.html

  • Sdílejte na:
    • Facebook
    • Twitter
    • Del.icio.us
    • Digg
    • Google
    • Reddit
    • StumbleUpon
    • Live

Podpora ČOS

Podpora Linkos.cz 

Děkujeme za podporu Linkos.cz! 

I my podporujeme 

Mezi členy ČOS je mnoho DOBRÝCH ANDĚLŮ, kteří přispívají rodinám, jež se vinou nemoci dostali do finanční tísně, ale také těch, kteří zprostředkují pomoc nadace DOBRÝ ANDĚL svým pacientům.